Fact CheckerSign in

NCT01480440Active, not recruiting

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System

Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Should System Used in Primary or Revision Reverse Total Shoulder Arthroplasty

Source: ClinicalTrials.gov · Last updated 28 Apr 2026

Brief summary (registry, in English)

The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
23 Nov 2011
Start date
Jan 2011
Primary completion date
Dec 2026
Lead sponsor
Zimmer Biomet
NCT number
NCT01480440

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From Jan 2011 to the primary completion date, Dec 2026
  • 5 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • The patient is a known alcohol or drug abuser;

Other illness

  • The patient has one of the following compromising the affected limb: a significant injury to the upper brachial plexus, paralysis of the axillary nerve or a neuromuscular disease compromising the affected limb which would render the procedure unjustifiable;
  • The patient has a local/systemic infection;
  • The patient has a known sensitivity or allergic reaction to one or more of the implanted materials;

Other

  • The patient is a prisoner;
  • The patient is mentally incompetent or unable to understand what participation in the study entails;
  • The patient is anticipated to be non-compliant;
  • The patient is known to be pregnant;
  • The patient has marked bone loss;
  • The patient is unwilling or unable to give consent or to comply with the follow-up program.

Who the study is looking for

  • Patient is \> 18 years of age;
  • Patient is skeletally mature;
  • Patient qualifies for primary or revision unilateral or bilateral reverse total shoulder arthroplasty based on physical exam and medical history including the following: osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, ununited humeral head fracture, irreducible 3-and 4-part proximal humeral fractures, avascular necrosis, gross rotator cuff deficiency or failed total shoulder arthroplasty (both glenoid and humeral components require revision);
  • Patient is willing and able to provide written informed consent;
  • Patient is willing and able to cooperate in the required post-operative therapy;
  • Patient is willing and able to complete scheduled follow-up evaluations/questionnaires as described in the Informed Consent;
  • Patient has participated in the Informed Consent process and has signed the Institutional Review Board (IRB)/Ethical Review Board (ERB) approved informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Royal Blackburn Hospital
Coordinator of this site? Confirm its status
BlackburnUnited KingdomUnknown status
The Rothman Institute
Coordinator of this site? Confirm its status
Egg HarborUnited StatesUnknown status
Norton Orthopaedic & Sports Medicine
Coordinator of this site? Confirm its status
LouisvilleUnited StatesUnknown status
The Rothman Institute
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
University of California San Francisco
Coordinator of this site? Confirm its status
San FranciscoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.